Scientific paper - Letter
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis
Annals of Hematology, 100 (2021), 4; 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, Marko; Galušić, Davor; Sorić, Ena; Sedinić, Martina; Ćubela, Marta; Huzjan Korunić, Renata; Pejša, Vlatko; Kušec, Rajko

Cite this document

Lucijanić, M., Galušić, D., Sorić, E., Sedinić, M., Ćubela, M., Huzjan Korunić, R. ... Kušec, R. (2021). Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology, 100. (4), 1105-1106. doi: 10.1007/s00277-020-04243-8

Lucijanić, Marko, et al. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology, vol. 100, no. 4, 2021, pp. 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, Marko, Davor Galušić, Ena Sorić, Martina Sedinić, Marta Ćubela, Renata Huzjan Korunić, Vlatko Pejša and Rajko Kušec. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology 100, no. 4 (2021): 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, M., et al. (2021) 'Ruxolitinib treatment improves muscle mass in patients with myelofibrosis', Annals of Hematology, 100(4), pp. 1105-1106. doi: 10.1007/s00277-020-04243-8

Lucijanić M, Galušić D, Sorić E, Sedinić M, Ćubela M, Huzjan Korunić R, and sur.. Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology [Internet]. 2021 April [cited 2024 February 29];100(4):1105-1106. doi: 10.1007/s00277-020-04243-8

M. Lucijanić, et al., "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis", Annals of Hematology, vol. 100, no. 4, pp. 1105-1106, April 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:268065. [Accessed: 29 February 2024]

Please login to the repository to save this object to your list.